Posted by Michael Wonder on 21 Jul 2019
A drug that treats cystic fibrosis has been listed on the Pharmaceutical Benefits Scheme
21 July 2019 - A medication to treat cystic fibrosis that costs patients up to $380,000 a year has been added to the Pharmaceutical Benefits Scheme.
Kalydeco did not just change Scarlett Fox’s life, it extended it.
Born with cystic fibrosis, the now five-year-old had struggled to gain weight and was “quite a sick little baby”, mum Sam Jesney said.
